Physician profile
Jie Cheng
NPI 1629176219
$82,345.16
in general payments reported to CMS, 2019-2025
26 companies · $61K in 2025
The $61K reported for 2025 was more than what 96% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,222 · 2021: $3,067 · 2022: $1,013 · 2023: $617 · 2024: $1,886 · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Food and Beverage: $1,783 · Travel and Lodging: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,511.05 |
| Food and Beverage | $1,783.17 |
| Travel and Lodging | $1,340.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mesoblast, INC. | $60,511.05 | 2025 | Ryoncil |
| Biotronik INC. | $10,211.30 | 2019-2025 | |
| Abbott Laboratories | $5,257.23 | 2019-2025 | Ensite Precision, Assurity, Gallant |
| Medtronic, INC. | $1,564.31 | 2021-2024 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Acutus Medical, INC. | $1,258.31 | 2019-2021 | |
| Boston Scientific Corporation | $1,021.86 | 2019-2025 | Watchman Access System, Vigilant X4 Crt-D, Watchman Flx |
| Cook Incorporated | $503.84 | 2020 | |
| Janssen Pharmaceuticals, INC | $360.90 | 2019-2022 | |
| Biosense Webster, INC. | $325.58 | 2019-2024 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $246.52 | 2021-2025 | Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $189.47 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $135.44 | 2019-2023 | Eliquis |
| Edwards Lifesciences Corporation | $113.50 | 2020 | |
| Sanofi-Aventis U.S. LLC | $100.10 | 2019-2022 | |
| Altathera Pharmaceuticals LLC | $93.91 | 2021-2024 | Sotalol Hydrochloride |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $66.65 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $65.48 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $57.46 | 2021 | |
| Angiodynamics, INC. | $49.58 | 2021 | |
| Irhythm Technologies, INC. | $39.65 | 2023 | Zio Xt Patch |
| Atricure, INC. | $37.79 | 2021 | |
| Pfizer INC. | $36.87 | 2020-2025 | |
| Cardiva Medical, INC. | $25.71 | 2022 | |
| Cook Medical LLC | $25.57 | 2019 | |
| Preventice Services, LLC | $24.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jie Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.